ReviewJACC. Basic to translational science
Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A State-of-the-Art Review.
Review in JACC. Basic to translational science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed.
- T-cell repertoire response in individuals with post-acute sequelae of COVID-19.bioRxiv : the preprint server for biology · 2026Article
- Article
- Post-COVID-19 condition symptoms among emergency department patients tested for SARS-CoV-2 infection.Nature communications · 2024Article
- Understanding contextual and practical factors to inform WHO recommendations on using chest imaging to monitor COVID-19 pulmonary sequelae: a qualitative study exploring stakeholders' perspective.Health research policy and systems · 2024Article
- Research progress of post-acute sequelae after SARS-CoV-2 infection.Cell death & disease · 2024Review
- COVID-19 with Suspected Secondary Pyogenic Arthritis of the Hip: A Case Report and Literature Review.Journal of orthopaedic case reports · 2024Article
- Pituitary-Adrenal Axis and Peripheral Immune Cell Profile in Long COVID.Biomedicines · 2024Article
- The effect of pressing needle therapy on depression, anxiety, and sleep for patients in convalescence from COVID-19.Frontiers in neurology · 2024Article
- Illness Experiences of Brazilian People Who Were Hospitalized Due to COVID-19 and Faced Long COVID Repercussions in Their Daily Life: A Constructivist Grounded Theory Study.Behavioral sciences (Basel, Switzerland) · 2023Article
- Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases.Science translational medicine · 2023Article
- COVID-19 infection and ambulatory surgery: Decision making based on known knowns.Best practice & research. Clinical anaesthesiology · 2023Review
- Efficacy and safety of acupuncture for post-COVID-19 depression: a protocol for systematic review and meta-analysis.BMJ open · 2023Article
- Post-acute sequelae of COVID-19 is characterized by diminished peripheral CD8Nature communications · 2023Article
- Cluster analysis of COVID-19 recovery center patients at a clinic in Boston, MA 2021-2022: impact on strategies for access and personalized care.Archives of public health = Archives belges de sante publique · 2023Article
- Elevated circulating monocytes and monocyte activation in COVID-19 convalescent individuals.Frontiers in immunology · 2023Article
- Long-term outcomes of COVID-19 intensive care unit survivors and their family members: a one year follow-up prospective study.Frontiers in public health · 2023Observational
- Long COVID and rheumatology: Clinical, diagnostic, and therapeutic implications.Best practice & research. Clinical rheumatology · 2022Review
- Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19.medRxiv : the preprint server for health sciences · 2022Article
- European Psychiatric Association-European Academy of Neurology statement on post-COVID syndrome.European psychiatry : the journal of the Association of European Psychiatrists · 2022Article
- Comparative study shows that 1 in 7 Spanish children with COVID-19 symptoms were still experiencing issues after 12 weeks.Acta paediatrica (Oslo, Norway : 1992) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The vast majority of patients (>99%) with severe acute respiratory syndrome coronavirus 2 survive immediate infection but remain at risk for persistent and/or delayed multisystem. This review of published reports through May 31, 2021, found that manifestations of postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection (PASC) affect between 33% and 98% of coronavirus disease 2019 survivors and comprise a wide range of symptoms and complications in the pulmonary, cardiovascular, neurologic, psychiatric, gastrointestinal, renal, endocrine, and musculoskeletal systems in both adult and pediatric populations. Additional complications are likely to emerge and be identified over time. Although data on PASC risk factors and vulnerable populations are scarce, evidence points to a disproportionate impact on racial/ethnic minorities, older patients, patients with preexisting conditions, and rural residents. Concerted efforts by researchers, health systems, public health agencies, payers, and governments are urgently needed to better understand and mitigate the long-term effects of PASC on individual and population health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.